Breaking Down AI's Role in Genomics and Polygenic Risk Prediction - with Dan Elton of the National Human Genome Research Institute

Breaking Down AI's Role in Genomics and Polyg...

Daniel FaggellaDaniel Faggella

Up next

In a Sea of Complexity, Does a "Successor" Exist? - with Stephen Wolfram of Wolfram Research

Today's guest is Stephen Wolfram, Founder and CEO of Wolfram Research. Wolfram is a pioneering computer scientist and physicist, best known for creating Mathematica and Wolfram|Alpha, and for decades of work on complexity, computation, and the foundations of how systems evolve. S ...  Show more

 . 2h 4min
From Demos to Defensible in Financial Services Copyright & Compliance for Enterprise AI - Naveen Kumar of TD Bank

Today's guest is Naveen Kumar, Head of AI Governance at TD Bank. With extensive experience in AI risk management and governance, he provides actionable strategies for secure AI scaling in regulated environments. Naveen joins Emerj Editorial Director Matthew DeMello to discuss fou ...  Show more

 . 19min 29sec

Recommended Episodes

The AI Will See You Now: Exploring Biomedical AI and Google’s Med-PaLM2 With Karan Singhal
No Priors: Artificial Intelligence | Technology | Startups

What if AI could revolutionize healthcare with advanced language learning models? Sarah and Elad welcome Karan Singhal, Staff Software Engineer at Google Research, who specializes in medical AI and the development of MedPaLM2. On this episode, Karan emphasizes the importance of s ...  Show more

 . 42min 48sec
#309 ‒ AI in medicine: its potential to revolutionize disease prediction, diagnosis, and outcomes, causes for concern in medicine and beyond, and more | Isaac Kohane, M.D., Ph.D.
The Peter Attia Drive

View the Show Notes Page for This Episode

<a href= "https://peterattiamd.com/subscribe/?utm_s ...

  Show more

 . 1h 55min
How AI Will Accelerate Breakthroughs in Biotechnology with Benchling CEO Sajith Wickramasekara
No Priors: Artificial Intelligence | Technology | Startups

Bringing new drugs to market is a costly, time-consuming endeavor. On top of that, most medicines fail at some point in the research and development phase. Sarah Guo is joined by Sajith Wickramasekara, co-founder and CEO of Benchling, a company that has not only become the centra ...  Show more

 . 48min 13sec
From AlphaFold to MMseqs2-GPU: How AI is Accelerating Protein Science - Ep. 273
NVIDIA AI Podcast

Listen as two leading researchers at the cutting edge of computational biology explore breakthrough GPU accelerations that are changing how we understand life's molecular machinery. Chris Dallago, Research Lead at NVIDIA and Visiting Professor at Duke University, and Martin Stein ...  Show more

 . 34min 37sec